167 Troglitazone PPTs View free & download

TROGLITAZONE: PRESENTATION TO ADVISORY COMMITTEE PowerPoint PPT Presentation

TROGLITAZONE: PRESENTATION TO ADVISORY COMMITTEE - Marketing in US began March 97. Adv Cmt (12/11/96) 8-0 vote for AP ... Adv Cmt (3/26/99) 11-1 B R for concomitant use with insulin; 12-0 B R for ...

Marketing in US began March 97. Adv Cmt (12/11/96) 8-0 vote for AP ... Adv Cmt (3/26/99) 11-1 B R for concomitant use with insulin; 12-0 B R for ...

| PowerPoint PPT presentation | free to download

Organic Ion Transporters PowerPoint PPT Presentation

Organic Ion Transporters - There are a variety of transporters and they are classified into ... Uptake of Troglitazone Sulfate by Xenopus Oocytes Expressed with OATP-C, OATP8 and OATP-B ...

There are a variety of transporters and they are classified into ... Uptake of Troglitazone Sulfate by Xenopus Oocytes Expressed with OATP-C, OATP8 and OATP-B ...

| PowerPoint PPT presentation | free to view

TRIPOD: Treating insulin resistance reduces incidence of type 2 diabetes PowerPoint PPT Presentation

TRIPOD: Treating insulin resistance reduces incidence of type 2 diabetes - TRIPOD: Treating insulin resistance reduces incidence of type 2 diabetes. TRoglitazone In Prevention Of Diabetes. n = 236 Hispanic women with gestational diabetes ...

TRIPOD: Treating insulin resistance reduces incidence of type 2 diabetes. TRoglitazone In Prevention Of Diabetes. n = 236 Hispanic women with gestational diabetes ...

| PowerPoint PPT presentation | free to view

Recent Withdrawals PowerPoint PPT Presentation

Recent Withdrawals - Title: Developing Consumer Marketing Claims within the Clinical Development Process Author: Lou Morris Created Date: 9/29/2000 3:30:09 PM Document presentation format

Title: Developing Consumer Marketing Claims within the Clinical Development Process Author: Lou Morris Created Date: 9/29/2000 3:30:09 PM Document presentation format

| PowerPoint PPT presentation | free to download

Potential role of PPAR activation in CV risk reduction PowerPoint PPT Presentation

Potential role of PPAR activation in CV risk reduction - in CV risk reduction Genetic background Food intake excess Physical inactivity Obesity Hyperglycemia Hyperinsulinemia Insulin Dyslipidemia Inflammation

in CV risk reduction Genetic background Food intake excess Physical inactivity Obesity Hyperglycemia Hyperinsulinemia Insulin Dyslipidemia Inflammation

| PowerPoint PPT presentation | free to view

Molecular Carcinogenesis 43: 198-205 PowerPoint PPT Presentation

Molecular Carcinogenesis 43: 198-205 - He, G., S. Muga, P. Thuillier, R.A. Lubert, S.M. Fischer Molecular Carcinogenesis 43: 198-205 What is PPAR-g? Peroxisome proliferator-activated receptor-gamma: member ...

He, G., S. Muga, P. Thuillier, R.A. Lubert, S.M. Fischer Molecular Carcinogenesis 43: 198-205 What is PPAR-g? Peroxisome proliferator-activated receptor-gamma: member ...

| PowerPoint PPT presentation | free to view

Rosiglitazone and Pioglitazone Alter Aromatase Kinetic Properties in Human Granulosa Cells PowerPoint PPT Presentation

Rosiglitazone and Pioglitazone Alter Aromatase Kinetic Properties in Human Granulosa Cells - Title: Vitamin D Intoxication due to Manufacturing and Labeling Errors of a Dietary Supplement: A Case Report Author: Takako Araki Last modified by

Title: Vitamin D Intoxication due to Manufacturing and Labeling Errors of a Dietary Supplement: A Case Report Author: Takako Araki Last modified by

| PowerPoint PPT presentation | free to download

Prevention Of Diabetes PowerPoint PPT Presentation

Prevention Of Diabetes - Prevention Of Diabetes A Dream Or A Reality By Professor Dr Intekhab Alam Department of Medicine Postgraduate Medical Institute, Lady Reading Hospital ...

Prevention Of Diabetes A Dream Or A Reality By Professor Dr Intekhab Alam Department of Medicine Postgraduate Medical Institute, Lady Reading Hospital ...

| PowerPoint PPT presentation | free to view

Part 2 Thyroid hormones and antithyroid drugs - Part 2 Thyroid hormones and antithyroid drugs

Part 2 Thyroid hormones and antithyroid drugs

| PowerPoint PPT presentation | free to view

Insulin - Pioglitazone has not been tested in patients with NYHA class III and IV cardiac status ... Pioglitazone (45 mg qd) LDL-C. HDL-C. TG. King AB. Diabetes Care 2000; ...

Pioglitazone has not been tested in patients with NYHA class III and IV cardiac status ... Pioglitazone (45 mg qd) LDL-C. HDL-C. TG. King AB. Diabetes Care 2000; ...

| PowerPoint PPT presentation | free to view

Procainamide PowerPoint PPT Presentation

Procainamide - Procainamide Unchanged in Urine, 59% 24% Fast 17% Slow 3% Unchanged in Urine, 85% 1% NAPA 0.3% Procainamide Additional Effects on Drug Metabolism Species Differences ...

Procainamide Unchanged in Urine, 59% 24% Fast 17% Slow 3% Unchanged in Urine, 85% 1% NAPA 0.3% Procainamide Additional Effects on Drug Metabolism Species Differences ...

| PowerPoint PPT presentation | free to download

Type 2 Diabetes Management Goals PowerPoint PPT Presentation

Type 2 Diabetes Management Goals - LDL-Cholesterol 100 mg/dL (Statins) BP 130/85 mm Hg (ACE inhibitors) ... Avoiding polypharmacy and complex regimens. Compliance and convenience. Cost ...

LDL-Cholesterol 100 mg/dL (Statins) BP 130/85 mm Hg (ACE inhibitors) ... Avoiding polypharmacy and complex regimens. Compliance and convenience. Cost ...

| PowerPoint PPT presentation | free to view

master template PowerPoint PPT Presentation

master template - Type 2 Diabetes Update. Prevention and Treatment. Bruce W. Bode, MD, FACE ... Amyloid. deposition. Insulin resistance 'lipotoxicity' elevated FFA,TG ...

Type 2 Diabetes Update. Prevention and Treatment. Bruce W. Bode, MD, FACE ... Amyloid. deposition. Insulin resistance 'lipotoxicity' elevated FFA,TG ...

| PowerPoint PPT presentation | free to download

Insulin Sensitizers: Surrogate and Clinical Outcomes Studies PowerPoint PPT Presentation

Insulin Sensitizers: Surrogate and Clinical Outcomes Studies - Number at risk Pioglitazone 2488 2373 2302 2218 2146 348 Placebo 2530 2413 2317 2215 2122 345 5 10 15 25 0 6 20 0 12 18 24 30 36 Pioglitazone (514 events) ...

Number at risk Pioglitazone 2488 2373 2302 2218 2146 348 Placebo 2530 2413 2317 2215 2122 345 5 10 15 25 0 6 20 0 12 18 24 30 36 Pioglitazone (514 events) ...

| PowerPoint PPT presentation | free to view

Potential role of PPAR activation in CV risk reduction - VBWG. Potential role of PPAR activation. in CV ... 2003;302:406-7. Peroxisome proliferator-activator. receptors ... Pioglitazone Actos Eli Lilly/ 1999 Takeda ...

VBWG. Potential role of PPAR activation. in CV ... 2003;302:406-7. Peroxisome proliferator-activator. receptors ... Pioglitazone Actos Eli Lilly/ 1999 Takeda ...

| PowerPoint PPT presentation | free to view

Oral Diabetes Medications PowerPoint PPT Presentation

Oral Diabetes Medications - Title: PowerPoint Presentation Last modified by: Carol Cordy Created Date: 1/1/1601 12:00:00 AM Document presentation format: On-screen Show Other titles

Title: PowerPoint Presentation Last modified by: Carol Cordy Created Date: 1/1/1601 12:00:00 AM Document presentation format: On-screen Show Other titles

| PowerPoint PPT presentation | free to view

Prediabetes - Title: Prediabetes Author: Carol Wysham Last modified by: burchett Created Date: 6/9/1998 2:55:14 PM Document presentation format: 35mm Slides Other titles

Title: Prediabetes Author: Carol Wysham Last modified by: burchett Created Date: 6/9/1998 2:55:14 PM Document presentation format: 35mm Slides Other titles

| PowerPoint PPT presentation | free to view

Insulin and oral hypoglycemic drugs PowerPoint PPT Presentation

Insulin and oral hypoglycemic drugs - Title: Pharmacology Author: zcy Last modified by * Created Date: 8/24/2002 2:50:00 AM Document presentation format: Company

Title: Pharmacology Author: zcy Last modified by * Created Date: 8/24/2002 2:50:00 AM Document presentation format: Company

| PowerPoint PPT presentation | free to view

Spectrum of Insulin Resistance: From Benign to Type 2 Diabetes - Spectrum of Insulin Resistance: From Benign to Type 2 Diabetes

Spectrum of Insulin Resistance: From Benign to Type 2 Diabetes

| PowerPoint PPT presentation | free to view

TYPE 2 DIABETES MELLITUS PowerPoint PPT Presentation

TYPE 2 DIABETES MELLITUS - TYPE 2 DIABETES MELLITUS Richard Sachson MD DIABETES AND GESTATIONAL DIABETES AMONG ADULTS IN THE U.S. -2001 Diabetes and Obesity: The Continuing Epidemic ...

TYPE 2 DIABETES MELLITUS Richard Sachson MD DIABETES AND GESTATIONAL DIABETES AMONG ADULTS IN THE U.S. -2001 Diabetes and Obesity: The Continuing Epidemic ...

| PowerPoint PPT presentation | free to download

master template - Prevalence of Diabetes in the US Goals of Intensive Diabetes Management Near-normal glycemia HbA1c less than 6.5 to 7.0% Avoid short-term crisis Hypoglycemia ...

Prevalence of Diabetes in the US Goals of Intensive Diabetes Management Near-normal glycemia HbA1c less than 6.5 to 7.0% Avoid short-term crisis Hypoglycemia ...

| PowerPoint PPT presentation | free to download

Targeting the Underlying Pathophysiology of Type 2 Diabetes PowerPoint PPT Presentation

Targeting the Underlying Pathophysiology of Type 2 Diabetes - Targeting the Underlying Pathophysiology of Type 2 Diabetes Aim Provide practical guidance on improving diabetes care through highlighting the need to: understand ...

Targeting the Underlying Pathophysiology of Type 2 Diabetes Aim Provide practical guidance on improving diabetes care through highlighting the need to: understand ...

| PowerPoint PPT presentation | free to view

WITHDRAWN OR REMOVED DRUG PRODUCTS PowerPoint PPT Presentation

WITHDRAWN OR REMOVED DRUG PRODUCTS - Must not compound drugs that appear on a list published in the Federal ... Analgesic and antipyretic. Caused agranulocytosis. Declared a 'new drug' in 1964 ...

Must not compound drugs that appear on a list published in the Federal ... Analgesic and antipyretic. Caused agranulocytosis. Declared a 'new drug' in 1964 ...

| PowerPoint PPT presentation | free to download

DREAM - DREAM Diabetes REduction Assessment with ramipril and rosiglitazone Medication Prevention of Type 2 Diabetes Clinical trials have shown that diet & exercise can ...

DREAM Diabetes REduction Assessment with ramipril and rosiglitazone Medication Prevention of Type 2 Diabetes Clinical trials have shown that diet & exercise can ...

| PowerPoint PPT presentation | free to download

SINDROM OVARIUM POLIKISTIK (SOPK) dan INFERTILITAS PowerPoint PPT Presentation

SINDROM OVARIUM POLIKISTIK (SOPK) dan INFERTILITAS - SINDROM OVARIUM POLIKISTIK (SOPK) dan INFERTILITAS Andon Hestiantoro Divisi Imunoendokrinologi Reproduksi Departemen Obstetri dan Ginekologi FKUI/RSCM

SINDROM OVARIUM POLIKISTIK (SOPK) dan INFERTILITAS Andon Hestiantoro Divisi Imunoendokrinologi Reproduksi Departemen Obstetri dan Ginekologi FKUI/RSCM

| PowerPoint PPT presentation | free to download

Diabetic Disorders PowerPoint PPT Presentation

Diabetic Disorders - Elevated triglycerides and LDL; reduced HDL; High blood pressure; obesity; ... Phenformin induces lactic acidosis .... Fatal in 3 ...

Elevated triglycerides and LDL; reduced HDL; High blood pressure; obesity; ... Phenformin induces lactic acidosis .... Fatal in 3 ...

| PowerPoint PPT presentation | free to download

Clinical Manifestations of Insulin Resistance PowerPoint PPT Presentation

Clinical Manifestations of Insulin Resistance - The Bad News: The Epidemic Of Obesity And Diabetes Is Worsening In The USA ... Increased incidence probably due to increased obesity and decreased physical activity1 ...

The Bad News: The Epidemic Of Obesity And Diabetes Is Worsening In The USA ... Increased incidence probably due to increased obesity and decreased physical activity1 ...

| PowerPoint PPT presentation | free to view

Evaluation and Treatment of Polycystic Ovary Syndrome _ PCOS Symptoms - Evaluation and Treatment of Polycystic Ovary Syndrome _ PCOS Symptoms

Evaluation and Treatment of Polycystic Ovary Syndrome _ PCOS Symptoms

| PowerPoint PPT presentation | free to download

Insulin Resistance and Cardiovascular Disease: PowerPoint PPT Presentation

Insulin Resistance and Cardiovascular Disease: - III. Insulin sensitizers: Surrogate and clinical. outcomes studies. IV. ... N = 266 Hispanic women with gestational diabetes randomized ...

III. Insulin sensitizers: Surrogate and clinical. outcomes studies. IV. ... N = 266 Hispanic women with gestational diabetes randomized ...

| PowerPoint PPT presentation | free to view

Flow of information in a drug discovery pipeline PowerPoint PPT Presentation

Flow of information in a drug discovery pipeline - Title: Cytochrome P450 and Polymorphism Subject: Cytochrome P450, ADME, Polymorphisms Author: Michael Hutter Last modified by: Michael Hutter Created Date

Title: Cytochrome P450 and Polymorphism Subject: Cytochrome P450, ADME, Polymorphisms Author: Michael Hutter Last modified by: Michael Hutter Created Date

| PowerPoint PPT presentation | free to view

TZDs and Atherosclerosis: Evolution from Translational to Clinical Science - TZDs and Atherosclerosis: Evolution from Translational to Clinical Science

TZDs and Atherosclerosis: Evolution from Translational to Clinical Science

| PowerPoint PPT presentation | free to view

CV Risk Reduction, Diabetes Prevention, and TZDs - CV Risk Reduction, Diabetes Prevention, and TZDs

CV Risk Reduction, Diabetes Prevention, and TZDs

| PowerPoint PPT presentation | free to view

management of diabetes mellitus - management of diabetes mellitus

management of diabetes mellitus

| PowerPoint PPT presentation | free to view

This presentation is made possible by a grant entitled PowerPoint PPT Presentation

This presentation is made possible by a grant entitled - ... glycerol to glucose ( = gluconeogenesis) then secretes it into ... Act by inhibiting liver gluconeogenesis & increasing insulin sensitivity in other tissues ...

... glycerol to glucose ( = gluconeogenesis) then secretes it into ... Act by inhibiting liver gluconeogenesis & increasing insulin sensitivity in other tissues ...

| PowerPoint PPT presentation | free to download

This presentation is made possible by a grant entitled - Over 16 million in the US have clinically diagnosed diabetes mellitus; about 8 ... (tronadora), brickle bush (prodigiosa) tea, or sage tea (salvia) are used. ...

Over 16 million in the US have clinically diagnosed diabetes mellitus; about 8 ... (tronadora), brickle bush (prodigiosa) tea, or sage tea (salvia) are used. ...

| PowerPoint PPT presentation | free to download

Insulin Resistance and Cardiovascular Diseases PowerPoint PPT Presentation

Insulin Resistance and Cardiovascular Diseases - 2002.11.02. . . ... Hyun Ho Shin, M.D. Department of Medicine Samsung Cheil Hospital Sungkyunkwan Univ. School of Medicine

2002.11.02. . . ... Hyun Ho Shin, M.D. Department of Medicine Samsung Cheil Hospital Sungkyunkwan Univ. School of Medicine

| PowerPoint PPT presentation | free to view

CM - ICTERE: Pr PowerPoint PPT Presentation

CM - ICTERE: Pr - Title: TD ICTERE Author: Beaujon Last modified by: VALLA Dominique Created Date: 9/16/2005 8:02:40 AM Document presentation format: Diapositives 35 mm

Title: TD ICTERE Author: Beaujon Last modified by: VALLA Dominique Created Date: 9/16/2005 8:02:40 AM Document presentation format: Diapositives 35 mm

| PowerPoint PPT presentation | free to download

Journal Club PowerPoint PPT Presentation

Journal Club - Journal Club Bernard Zinman, Stewart B Harris, Jan Neuman, Hertzel C Gerstein, Ravi R Retnakaran, Janet Raboud, Ying Qi, Anthony J G Hanley Low-dose combination ...

Journal Club Bernard Zinman, Stewart B Harris, Jan Neuman, Hertzel C Gerstein, Ravi R Retnakaran, Janet Raboud, Ying Qi, Anthony J G Hanley Low-dose combination ...

| PowerPoint PPT presentation | free to download

Les antidiab PowerPoint PPT Presentation

Les antidiab - Les antidiab tiques oraux Les anciennes et les nouvelles mol cules et strat gies envisageables Pr Serge HALIMI

Les antidiab tiques oraux Les anciennes et les nouvelles mol cules et strat gies envisageables Pr Serge HALIMI

| PowerPoint PPT presentation | free to download

Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial PowerPoint PPT Presentation

Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial - Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial ... 9% RRR in new-onset diabetes or death (nonsignificant) ...

Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial ... 9% RRR in new-onset diabetes or death (nonsignificant) ...

| PowerPoint PPT presentation | free to download

Jaundice - www.drsarma.in * Post hepatic Obstructive Jaundice Painful v/s painless Obstruction can be Luminal (stone) Stricture (benign v/s cholangiocarcinoma) ...

www.drsarma.in * Post hepatic Obstructive Jaundice Painful v/s painless Obstruction can be Luminal (stone) Stricture (benign v/s cholangiocarcinoma) ...

| PowerPoint PPT presentation | free to download

Antidiabetic Drugs PowerPoint PPT Presentation

Antidiabetic Drugs - Lecture 14 Chapter 46 Antidiabetic Drugs Antidiabetic Drugs Drugs used to control diabetes mellitus - a chronic disease that affects carbohydrate metabolism 2 groups ...

Lecture 14 Chapter 46 Antidiabetic Drugs Antidiabetic Drugs Drugs used to control diabetes mellitus - a chronic disease that affects carbohydrate metabolism 2 groups ...

| PowerPoint PPT presentation | free to download

NAFLD Non-Alcoholic Fatty Liver Disease NASH Non-Alcoholic Steato-Hepatitis PowerPoint PPT Presentation

NAFLD Non-Alcoholic Fatty Liver Disease NASH Non-Alcoholic Steato-Hepatitis - NAFLD Non-Alcoholic Fatty Liver Disease NASH Non-Alcoholic Steato-Hepatitis Aspetti epidemiologici In USA 69% delle ipertransaminasemie = NAFLD NAFLD colpisce fino al ...

NAFLD Non-Alcoholic Fatty Liver Disease NASH Non-Alcoholic Steato-Hepatitis Aspetti epidemiologici In USA 69% delle ipertransaminasemie = NAFLD NAFLD colpisce fino al ...

| PowerPoint PPT presentation | free to view

Thiazolidinediones en Insulineresistentie PowerPoint PPT Presentation

Thiazolidinediones en Insulineresistentie - survey of 144 primary ... Results : - LDL cholesterol lower in the atorvastatin-group (79 ... ADIPOSE TISSUE IS THE MOST IMPORTANT ACTION OF TZD. Mechanisme van ...

survey of 144 primary ... Results : - LDL cholesterol lower in the atorvastatin-group (79 ... ADIPOSE TISSUE IS THE MOST IMPORTANT ACTION OF TZD. Mechanisme van ...

| PowerPoint PPT presentation | free to view

POLYCYSTIC OVARY SYNDROME SPOTLIGHTS PowerPoint PPT Presentation

POLYCYSTIC OVARY SYNDROME SPOTLIGHTS - Adipose tissue. acyclic estrogen. Adrenal androgen. Cyclic estrogen. Ovarian androgen ... in peripheral tissues (muscle and adipose tissue), but not in hepatic ...

Adipose tissue. acyclic estrogen. Adrenal androgen. Cyclic estrogen. Ovarian androgen ... in peripheral tissues (muscle and adipose tissue), but not in hepatic ...

| PowerPoint PPT presentation | free to view

3rd Annual Friedman Fellows Symposium PowerPoint PPT Presentation

3rd Annual Friedman Fellows Symposium - Title: Thiazolidinedione and bone turnover Author: Dell Last modified by: Administrator Document presentation format: On-screen Show Other titles

Title: Thiazolidinedione and bone turnover Author: Dell Last modified by: Administrator Document presentation format: On-screen Show Other titles

| PowerPoint PPT presentation | free to download

Diabetes Mellitus PowerPoint PPT Presentation

Diabetes Mellitus - Title: PowerPoint Presentation Author: Sufyan & Rasha Last modified by: Anthony Pomtree Created Date: 4/19/2002 4:45:18 AM Document presentation format

Title: PowerPoint Presentation Author: Sufyan & Rasha Last modified by: Anthony Pomtree Created Date: 4/19/2002 4:45:18 AM Document presentation format

| PowerPoint PPT presentation | free to view

The Role of TZDs in the Practical Management of Diabetes in Patients With Comorbid CVD Risk Factors PowerPoint PPT Presentation

The Role of TZDs in the Practical Management of Diabetes in Patients With Comorbid CVD Risk Factors - Not too long ago we were hunters and gatherers doing physical labor for our ... Postprandial blood glucose. Fasting blood glucose. Typical diagnosis of diabetes ...

Not too long ago we were hunters and gatherers doing physical labor for our ... Postprandial blood glucose. Fasting blood glucose. Typical diagnosis of diabetes ...

| PowerPoint PPT presentation | free to view

Pharmacology PowerPoint PPT Presentation

Pharmacology - Diminish side effects of estrogen therapy. Nausea, fluid retention, breast tenderness ... Antihypertensives & psychoactive drugs. sildenafil (Viagra ...

Diminish side effects of estrogen therapy. Nausea, fluid retention, breast tenderness ... Antihypertensives & psychoactive drugs. sildenafil (Viagra ...

| PowerPoint PPT presentation | free to view

DIABETES MELLITUS - Unexplained weight loss. Fasting BS 126 or Greater. NPO at Least 8 Hours ... Unexplained weight loss. Fasting BS 126 or greater. NPO at least 8 hours ...

Unexplained weight loss. Fasting BS 126 or Greater. NPO at Least 8 Hours ... Unexplained weight loss. Fasting BS 126 or greater. NPO at least 8 hours ...

| PowerPoint PPT presentation | free to view

Type 2 Diabetes in Children PowerPoint PPT Presentation

Type 2 Diabetes in Children - Type 2 Diabetes in Children Dr. Abdulmoein Al-Agha, MBBS,DCH,CABP, MRCP(UK) Consultant, Pediatric Endocrinologist, King AbdulAziz University Hospital, Jeddah.

Type 2 Diabetes in Children Dr. Abdulmoein Al-Agha, MBBS,DCH,CABP, MRCP(UK) Consultant, Pediatric Endocrinologist, King AbdulAziz University Hospital, Jeddah.

| PowerPoint PPT presentation | free to view

Diabetes Mellitus Type 2 PowerPoint PPT Presentation

Diabetes Mellitus Type 2 - Review medical therapies for type 2 DM. List important considerations in ... Slow absorption of carbohydrates and reduces rise in postprandial glucose levels ...

Review medical therapies for type 2 DM. List important considerations in ... Slow absorption of carbohydrates and reduces rise in postprandial glucose levels ...

| PowerPoint PPT presentation | free to view

Peroxisomes in Dermatology.ppt PowerPoint PPT Presentation

Peroxisomes in Dermatology.ppt - The biology of peroxisomes and their effect on skin biology and diseases development

The biology of peroxisomes and their effect on skin biology and diseases development

| PowerPoint PPT presentation | free to download

Peroxisomes in Dermatology PowerPoint PPT Presentation

Peroxisomes in Dermatology - The biology of peroxisomes and their effect on skin physiology and pathology

The biology of peroxisomes and their effect on skin physiology and pathology

| PowerPoint PPT presentation | free to download

Management of Type 2 Diabetes with Basal Bolus Treatment Strategies PowerPoint PPT Presentation

Management of Type 2 Diabetes with Basal Bolus Treatment Strategies - Suppresses glucose production between meals and overnight. 40% to 50% of ... Infection in colostomy pouch (ulcerative colitis) glucose up to. 300 mg/dL plus ...

Suppresses glucose production between meals and overnight. 40% to 50% of ... Infection in colostomy pouch (ulcerative colitis) glucose up to. 300 mg/dL plus ...

| PowerPoint PPT presentation | free to download

What is the metabolic syndrome? Simon Thom PowerPoint PPT Presentation

What is the metabolic syndrome? Simon Thom - What is the metabolic syndrome? Simon Thom Lipid Update VI Stratford-upon-Avon, 20/11/2006 The metabolic syndrome / insulin resistance syndrome / Reaven s syndrome ...

What is the metabolic syndrome? Simon Thom Lipid Update VI Stratford-upon-Avon, 20/11/2006 The metabolic syndrome / insulin resistance syndrome / Reaven s syndrome ...

| PowerPoint PPT presentation | free to download

Troglitazone PowerPoint PPT Presentations